tiprankstipranks
Trending News
More News >
Arbutus Biopharma (ABUS)
:ABUS
US Market
Advertisement

Arbutus Biopharma (ABUS) Technical Analysis

Compare
1,248 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Arbutus Biopharma’s (ABUS) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Arbutus Biopharma is a Buy.
Arbutus Biopharma’s (ABUS) 20-Day exponential moving average is 3.21, while Arbutus Biopharma’s (ABUS) share price is $3.15, making it a Sell.
Arbutus Biopharma’s (ABUS) 50-Day exponential moving average is 3.27, while Arbutus Biopharma’s (ABUS) share price is $3.15, making it a Sell.

Arbutus Biopharma (ABUS) Pivot Points

Jul 23, 2025, 03:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.04
3.07
3.11
3.14
3.18
3.21
3.25
Fibonacci
3.07
3.10
3.12
3.14
3.17
3.19
3.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Arbutus Biopharma (ABUS) Moving Averages

Jul 23, 2025, 03:16 PM
Period
Simple
Exponential
MA5
3.14Buy
3.15Buy
MA10
3.18Sell
3.17Sell
MA20
3.20Sell
3.21Sell
MA50
3.30Sell
3.27Sell
MA100
3.30Sell
3.32Sell
MA200
3.43Sell
3.47Sell
Arbutus Biopharma’s (ABUS) 10-Day exponential moving average is 3.17, while Arbutus Biopharma’s (ABUS) share price is $3.15, making it a Sell.
Arbutus Biopharma’s (ABUS) 100-Day exponential moving average is 3.32, while Arbutus Biopharma’s (ABUS) share price is $3.15, making it a Sell.
Arbutus Biopharma’s (ABUS) stock price is $3.15 and Arbutus Biopharma’s (ABUS) 50-day simple moving average is 3.30, creating a Sell signal.
Arbutus Biopharma’s (ABUS) stock price is $3.15 and Arbutus Biopharma’s (ABUS) 100-day simple moving average is 3.30, creating a Sell signal.
Arbutus Biopharma’s (ABUS) stock price is $3.15 and Arbutus Biopharma’s (ABUS) 200-day simple moving average is 3.43, creating a Sell signal.

Arbutus Biopharma (ABUS) Technical Indicators

Jul 23, 2025, 03:16 PM
Name
Value
Implied Action
RSI (14)
43.73
Neutral
STOCH (9,6)
22.25
Neutral
STOCHRSI (14)
26.60
Neutral
MACD (12,26)
-0.05
Buy
ADX (14)
18.28
Buy
Williams %R
-75.00
Buy
CCI (14)
-57.69
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
45.53
Neutral
ROC
-0.94
Sell
Arbutus Biopharma’s (ABUS) Relative Strength Index (RSI) is 43.73, creating a Neutral signal.
Arbutus Biopharma’s (ABUS) Trend Strength Indicator (ADX) is 18.28, creating a Buy signal.
Arbutus Biopharma’s (ABUS) Commodity Channel Index (CCI) is -57.69, creating a Neutral signal.
Arbutus Biopharma’s (ABUS) Price Rate of Change (ROC) is -0.94, creating a Sell signal.

FAQ

Is ABUS a Buy, Hold, or Sell?
Based on ABUS’s technical indicators, ABUS is a Sell.
    What is ABUS’s RSI (14)?
    ABUS’s RSI (14) is 43.73, which suggests ABUS is a Neutral.
      What is ABUS’s MACD?
      ABUS’s MACD is -0.05, which suggests ABUS is a Buy.
        What is ABUS’s 5-day moving average?
        ABUS’s 5-day moving average is 3.14, which suggests ABUS is a Buy.
          What is ABUS’s 20-day moving average?
          ABUS 20-day moving average is 3.20, which suggests ABUS is a Sell.
            What is ABUS’s 50-day moving average?
            ABUS’s 50-day moving average is 3.30, which suggests ABUS is a Sell.
              What is ABUS’s 200-day moving average?
              ABUS’s 200-day moving average is 3.43, which suggests ABUS is a Sell.
                What is ABUS’s Williams % R (14)?
                ABUS’s Williams % R (14) is -75.00, which suggests ABUS is a Buy.
                  What is ABUS’s CCI (14)?
                  ABUS’s CCI (14) is -57.69, which suggests ABUS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis